Scope
Reference
DACPM2025-27
Description
Procurement of ADCETRIS (BRENTUXIMAB VEDOTIN) 50MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION, 1 each
Contract 1. ADCETRIS (BRENTUXIMAB VEDOTIN) 50MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1 vial
Supplier
Contract value
- £700,000 excluding VAT
- £700,000 including VAT
Above the relevant threshold
Award decision date
21 May 2025
Standstill period
- End: 2 June 2025
- 8 working days
Earliest date the contract will be signed
16 June 2025
Contract dates (estimated)
- 17 June 2025 to 30 June 2027
- 2 years, 14 days
Main procurement category
Goods
CPV classifications
- 33600000 - Pharmaceutical products
Contract locations
- UKN - Northern Ireland
Procedure
Procedure type
Direct award
Supplier
ALLOGA UK LIMITED
- Companies House: 03169255
- Public Procurement Organisation Number: PBTH-6754-GVPN
Amber Park
Alfreton
DE55 2FH
United Kingdom
Email: allogauk.enquiries@alloga.co.uk
Website: https://www.alloga.co.uk/
Region: UKF12 - East Derbyshire
Small or medium-sized enterprise (SME): No
Voluntary, community or social enterprise (VCSE): No
Supported employment provider: No
Public service mutual: No
Contract 1. ADCETRIS (BRENTUXIMAB VEDOTIN) 50MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 1 vial
Contracting authority
Belfast Health & Social Care Trust
- Public Procurement Organisation Number: PLQJ-5727-JCLR
Trust Headquarters, 2nd Floor, Non Clinical Support Building, Royal Victoria Hospital
Belfast
BT12 6BA
United Kingdom
Region: UKN06 - Belfast
Organisation type: Public authority - central government
Devolved regulations that apply: Northern Ireland